These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditions. Riondino S; Martini F; La Farina F; Spila A; Guadagni F; Ferroni P Clin Biochem; 2010 May; 43(7-8):666-70. PubMed ID: 20060822 [TBL] [Abstract][Full Text] [Related]
25. Soluble CD40 ligand in acute coronary syndromes. Heeschen C; Dimmeler S; Hamm CW; van den Brand MJ; Boersma E; Zeiher AM; Simoons ML; N Engl J Med; 2003 Mar; 348(12):1104-11. PubMed ID: 12646667 [TBL] [Abstract][Full Text] [Related]
26. Relation of platelet activation to coronary angiographic severity and collateralization. Tan KT; Tayebjee MH; Macfadyen RJ; Lip GY Am J Cardiol; 2005 Jul; 96(2):208-10. PubMed ID: 16018843 [TBL] [Abstract][Full Text] [Related]
27. Potential role of soluble CD40 ligand as inflammatory biomarker in colorectal cancer patients. Dymicka-Piekarska V; Korniluk A; Gryko M; Siergiejko E; Kemona H Int J Biol Markers; 2014 Sep; 29(3):e261-7. PubMed ID: 24706377 [TBL] [Abstract][Full Text] [Related]
28. Platelet activation in heart failure patients supported by the HeartMate II ventricular assist device. Slaughter MS; Sobieski MA; Graham JD; Pappas PS; Tatooles AJ; Koenig SC Int J Artif Organs; 2011 Jun; 34(6):461-8. PubMed ID: 21725928 [TBL] [Abstract][Full Text] [Related]
30. Platelet activation and dysfunction in a large-animal model of traumatic brain injury and hemorrhage. Sillesen M; Johansson PI; Rasmussen LS; Jin G; Jepsen CH; Imam AM; Hwabejire J; Lu J; Duggan M; Velmahos G; deMoya M; Alam HB J Trauma Acute Care Surg; 2013 May; 74(5):1252-9. PubMed ID: 23609275 [TBL] [Abstract][Full Text] [Related]
31. Enhanced thrombogenesis but not platelet activation is associated with transcatheter closure of patent foramen ovale in patients with cryptogenic stroke. Bédard E; Rodés-Cabau J; Houde C; Mackey A; Rivest D; Cloutier S; Noël M; Marrero A; Côté JM; Chetaille P; Delisle G; Leblanc MH; Bertrand OF Stroke; 2007 Jan; 38(1):100-4. PubMed ID: 17122434 [TBL] [Abstract][Full Text] [Related]
32. Assessment of platelet activity by measuring platelet-derived substances in plasma from patients with acute myocardial infarction: surprising lessons from the GUSTO-III Platelet Study. Serebruany VL; Gurbel PA Thromb Res; 1999 Feb; 93(3):149-50. PubMed ID: 10030832 [No Abstract] [Full Text] [Related]
33. Reduced antiplatelet effect of aspirin is associated with low-grade inflammation in patients with coronary artery disease. Larsen SB; Grove EL; Kristensen SD; Hvas AM Thromb Haemost; 2013 May; 109(5):920-9. PubMed ID: 23407706 [TBL] [Abstract][Full Text] [Related]
34. Platelet reactivity in patients with a history of obstructive prosthetic valve thrombosis. Bouganim T; Shapira Y; Sagie A; Vaturi M; Battler A; Kornowski R; Lev EI Am J Cardiol; 2009 Jun; 103(12):1760-3. PubMed ID: 19539089 [TBL] [Abstract][Full Text] [Related]
35. Platelet-specific markers are associated with monocyte-platelet aggregate formation and thrombin generation potential in advanced atherosclerosis. Gremmel T; Ay C; Riedl J; Kopp CW; Eichelberger B; Koppensteiner R; Panzer S Thromb Haemost; 2016 Mar; 115(3):615-21. PubMed ID: 26467184 [TBL] [Abstract][Full Text] [Related]
36. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels. Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169 [TBL] [Abstract][Full Text] [Related]
37. Soluble CD40 ligand, soluble P-selectin and von Willebrand factor levels in subjects with prediabetes: the impact of metabolic syndrome. Genc H; Dogru T; Tapan S; Tasci I; Bozoglu E; Gok M; Aslan F; Celebi G; Erdem G; Avcu F; Ural AU; Sonmez A Clin Biochem; 2012 Jan; 45(1-2):92-5. PubMed ID: 22100896 [TBL] [Abstract][Full Text] [Related]
38. Enhanced platelet responsiveness due to chilling and its relation to CD40 ligand level and platelet-leukocyte aggregate formation. Ayukawa O; Nakamura K; Kariyazono H; Ikeda R; Arima J; Shinkawa T; Iwase H; Sakata R; Yamada K Blood Coagul Fibrinolysis; 2009 Apr; 20(3):176-84. PubMed ID: 19300046 [TBL] [Abstract][Full Text] [Related]
39. CD40 ligand--assessing risk instead of damage? Freedman JE N Engl J Med; 2003 Mar; 348(12):1163-5. PubMed ID: 12646674 [No Abstract] [Full Text] [Related]
40. Elevated levels of platelet-monocyte aggregates and related circulating biomarkers in patients with acute coronary syndrome. Wang J; Zhang S; Jin Y; Qin G; Yu L; Zhang J Int J Cardiol; 2007 Feb; 115(3):361-5. PubMed ID: 16887214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]